Cartesian begins CAR-T clinical trial in myasthenia gravis

Descartes-08 is designed to target plasma cells that express B-cell Maturation Antigen (BCMA) protein. Credit: University of Miami Health Systems.



  • Cartesian begins CAR-T clinical trial in myasthenia gravis